Synyi is a technology company.
智能医疗领导者，亿万生命守护人
Synyi has raised $16.0M across 1 funding round.
Synyi has raised $16.0M in total across 1 funding round.
Synyi has raised $16.0M in total across 1 funding round.
Synyi's investors include Granite Asia.
Synyi (also known as Synyi.ai or 森亿智能) is a healthcare technology company that develops AI and big data platforms to manage and analyze medical data, primarily for hospitals in China.[1][2][3] It offers solutions like hospital information systems, electronic medical records, medical data integration platforms, and semantic analysis tools that standardize unstructured hospital records using machine learning and natural language processing to optimize operations, patient care, and medical research.[2][3][5] Serving research hospitals, polyclinics, regional health networks, and institutions, Synyi addresses the challenge of handling vast, unstructured medical data to enable intelligent decision-making and smart hospital transformations.[1][3][4][6]
Founded in 2016 and headquartered in Pudong, China, the company has positioned itself as a leader in medical data governance, mining, and application, with pre-IPO shares available via platforms like EquityZen, indicating growth potential in the booming healthcare AI sector.[1][2][6]
Synyi emerged in 2016 amid China's push for digital healthcare transformation, focusing on the pain point of unstructured medical records prevalent in Chinese hospitals.[2][3][6] While specific founders are not detailed in available sources, the company was established in Pudong, China, as a specialist in big data-driven AI for medical research, healthcare, and patient services.[2][3] Early development centered on a semantic analysis system leveraging machine learning and natural language processing to collect, model, and analyze large-scale medical data, quickly gaining traction as a total solution provider for smart hospitals.[3][5] This positioned Synyi to capitalize on the growing demand for data intelligence in healthcare, evolving from data management to comprehensive AI-optimized hospital operations.[1][2]
Synyi stands out in the healthcare AI space through targeted innovations for China's medical ecosystem:
Synyi rides the healthcare AI wave, particularly in China where massive patient data volumes meet digitization needs, fueled by government initiatives for smart hospitals and AI integration in medicine.[2][5] Timing aligns with global healthcare AI market growth—projected at $36.22 billion from 2021-2026—amid post-pandemic demands for efficient data-driven care.[2] Market forces like increasing unstructured data in hospitals and AI advancements in analytics favor Synyi, enabling it to influence China's ecosystem by standardizing data for better research, operations, and regional health networks.[1][3][6] As a Pudong-based player, it contributes to Asia's healthcare tech hub, competing with global peers like Overjet or VideaHealth but dominating local medical data challenges.[2]
Synyi is poised for expansion as China's healthcare digitization accelerates, potentially scaling its platforms to more hospitals and exporting AI tools amid rising global demand for medical data intelligence. Trends like AI-enhanced diagnostics, regulatory support for health data standards, and big data analytics will shape its path, with pre-IPO status signaling investor interest.[1][2] Its influence may evolve from domestic data manager to international healthcare AI leader, building on its edge in unstructured data processing to drive smarter, more efficient patient care worldwide—cementing its role as a foundational player in medical tech innovation.[3][6]
Synyi has raised $16.0M across 1 funding round. Most recently, it raised $16.0M Series B in May 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2018 | $16.0M Series B | Granite Asia |